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The action of ginkgolide B (GB), the powerful compound of Ginkgo biloba extract, on glycine-
mediated spontaneous currents in rat spinal sacral dorsal commissural nucleus (SDCN) neurons 
was examined. IPSCs evoked in spinal cord slices were inhibited in a dose-dependent manner 
by the addition of GB to the superfusion solution. The amplitude of eIPSCs was reduced 
to 61 ± 6.4% by 10 µM GB, with acceleration of the kinetics of the currents indicating the 
effect of GB on channel pores.  Both the amplitude and success ratio (R
suc
) of eIPSC induced 
by electrical focal stimulation of single glycinergic nerve endings (boutons) also decreased 
in the presence of 1 µM GB.  These data suggest that GB modulates not only post-synaptic 
glycine receptors but also the pre-synaptic glycine release machinery.
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INTRODUCTION
Glycine and γ-aminobutyric acid (GABA) are 
considered to assemble fast synaptic inhibitory 
transmission within neuronal networks in the CNS [1]. 
The primary impact of glycine on the control of both 
motor and sensory pathways has been confirmed to be 
mediated throughout the brainstem and spinal cord [2]. 
A pharmacological influence of glycinergic inhibition 
by a glycine transporter produced a profound anti-
allodynia effect in a peripheral nerve partial ligation 
model in mice [3], whereas disinhibitory mechanisms 
may contribute to abnormal pain occurring after 
peripheral nerve injury [4]. Therefore, ligands for 
both GABA and glycine receptors have important 
implications in relative disease states and nociception, 
since these agents can potentially be used to relieve 
the pain [5, 6], whereas antagonists cause neuronal 
excitation. Such antagonists are often used to 
discriminate between receptor subtypes with respect 
to their brain region and/or cellular localization.
Remarkably, the functional alliance between the 
above-mentioned inhibitory transmitter systems 
has been proved for the intraspinal circuitry. The 
respective statements include the synaptic co-
localization of special receptors, the existence of 
functional transporters, and co-release of both active 
substances due to input stimulation [7]. Therefore, the 
development of selective pharmacological tools is a 
promising outline to control glycinergic transmission 
and modulate the neuronal excitability, especially in 
the spinal cord, since the latter was reported to serve as 
an intermediary “relay” formation for pain processing 
and suppression mechanisms, where the role of glycine 
receptors is beyond doubts. 
Strychnine-sensitive glycine receptors share the 
topology, transmembrane arrangement, and pentameric 
subunit assembly with members of the ligand-gated 
ion channel receptor superfamily [8]. The general 
similarities of receptor structure might predict the 
common influence of both glycine and GABA receptor 
types by the rank of modulators, as has been found for 
picrotoxin and strychnine [9]. 
A terpenic trilactone, ginkgolide B (GB), the 
powerful constituent from Ginkgo biloba extract 
demonstrated previously to be a platelet-activity 
factor (PAF) antagonist [10], is a blocker of glycine-
gated channels with a somewhat higher potency for β 
subunit-composed receptors, in particular α2β hetero-
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oligomers [11]. The efficacy of GB as an open-channel 
blocker was mainly investigated in hippocampal and 
cortex glycine receptors [12], i.e., in the brain regions 
never evidenced to compose pure glycinergic synapses, 
where glycine receptors are rarely expressed. The 
impact of inhibitory glycinergic transmission in these 
structures, if at all, seems to be a minor to GABA-
ergic. 
In the current study, we investigated the action of GB 
on glycine-mediated currents in spinal neurons of the 
rat sacral dorsal commissural nucleus (SDCN). Neurons 
from the SDCN are known to receive glycinergic, 
GABA-ergic, and mixed synaptic inputs [13, 14] 
and are implicated in pain perception [15, 16]. In an 
attempt to clarify the physiological relevance for GB 
as a channel blocker due to diverse “vivid” conditions 
for signal driving, we have examined the effect of GB 
on spontaneous and evoked inhibitory postsynaptic 
currents (sIPSCs and eIPSCs, respectively) both in 
spinal cord slices and in acutely isolated neurons with 
functional synaptic boutons remaining [13, 17]. Thus, 
we have compared here the effects of GB on sIPSCs 
in slices and single neurons, as well as on electrically 
induced eIPSCs in slices and with a focal single-bouton 
stimulation technique, i.e., in the situations reflecting 
the action of ginkgolides on glycine receptors within 
different transmission modes. 
METHODSs
Surgical procedures.  All experiments were performed 
in accordance with the Guiding Principles for Care 
and Use of Animals in the Field of Physiological 
Sciences of the Physiological Society of Japan and 
approved by the local Animal Experiment Committee 
in the Kumamoto Health Science University (Japan). 
Wistar rats (10-12 days old) were decapitated under 
pentobarbital anesthesia (50 mg/kg, i.p.). A segment of 
the lumbosacral (L5-S4) spinal cord was dissected and 
transversely sliced in ice-cold artificial cerebrospinal 
fluid at a thickness of 350-370 µm using a microslicer 
(VT1000S; Leica, Germany). Slices were kept in 
an incubation medium at room temperature (25°C). 
The incubation medium consisted of (mM): NaCl, 
124; KCl, 5; KH
2
PO
4
, 1.2; NaHCO
3
, 24; CaCl
2
, 2.4; 
MgSO
4
⋅7H
2
O, 1.3; and glucose 10; the saline was 
saturated with 95% O
2
 and 5% CO
2
 (pH 7.4). 
Slice preparation and isolation of neurons.  Slices 
were transferred to a recording chamber (volume 300 µl) 
that was continuously perfused with a normal 
external solution (mM): NaCl, 119; KCl, 2.5; CaCl
2
, 
2.5; MgSO
4
⋅7H
2
O, 1.3; NaH
2
PO
4
, 1; NaHCO
3
, 26.2; 
and glucose, 11, equilibrated with 95% O
2
+5% CO
2
 
and delivered with a gravity-fed perfusion system 
at a flow rate of 2-3 ml/min. Neurons of the SDCN 
(Fig. 1A) were visually identified with an infrared-
differential interference contrast (IR-DIC) video 
microscope (Leica DM SDK; IR-1000 (DAGE-
MTI, USA) and captured with CoolSNAP ES2 (CCD 
ICX285). The patch pipette solution for the whole-
cell patch recording in slice preparations consisted of 
(mM): Cs methanesulfonate, 145; TEA-Cl, 5; CsCl, 5; 
EGTA, 2, HEPES, 10 (pH 7.2). For suppression of the 
postsynaptic GABA
A
 responses, most experiments were 
performed in an internal solution without ATP, where 
the GABA
A
 response was eliminated by superfusion 
with an ATP-free internal solution [21, 22].
For mechanical dissociation, slices were transferred 
into a culture dish (Primaria 3801; Becton Dickinson, 
USA). The region of the SDCN (Fig. 1A) was identified 
under a binocular microscope. The details of mechanical 
dissociation have previously been described [23, 24]. 
Single SDCN neurons were acutely dissociated from 
slices using a manufactured vibrating cell-isolating 
setup (S-I L cell Isolator; KT Labo, Japan). Then, SDCN 
neurons were identified under microscopic visual 
control. The external solution used for dissociated 
neurons consisted of (mM): NaCl, 150; KCl, 5; 
CaCl
2
, 2; MgCl
2
, 1; glucose 10, and HEPES 10; pH 
was adjusted to 7.4 with Tris-OH. The composition of 
a pipette-filling solution for single-cell experiments 
was as follows (mM): CsF, 135; TEA-Cl, 5; CsCl, 5; 
EGTA, 2 and HEPES, 10, but without ATP; pH of the 
solution was adjusted to 7.2 with Tris-OH. 
Electrophysiological recordings.  All electrical 
measurements were performed using the conventional 
whole-cell patch recording mode at a holding potential 
(V
H
) of 0 mV using a patch-clamp amplifier (CEZ-
2300; Nihon Kohden, Japan). Patch electrodes were 
fabricated from borosilicate glass capillaries of a 1.5 mm 
outer diameter (Model GD-1.5, Narishige Scientific 
Instruments Lab, Japan) with a programmable puller 
(P-97; Sutter Instruments, USA). The tip resistance 
of the electrodes filled with the solution was 6-8 MΩ 
for slice preparations and 4-5 MΩ for dissociated 
neurons. Current and voltage values were continuously 
monitored on an oscilloscope and a pen recorder. The 
membrane currents were filtered at 1 kHz (E-3201A 
Decade Filter; NF Electronic Instruments, Japan), 
digitized at 4 ⋅ 10–3 sec–1, and stored on a computer 
equipped with pCLAMP 8.02 (Axon Instruments, 
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USA). To monitor the access resistance, 10 mV 
hyperpolarizing step pulses (30 msec long) were 
periodically delivered.
The SDCN neurons  receive glutamatergic, 
glycinergic, GABA-ergic, and mixed synaptic inputs. 
To isolate pharmacologically glycine-mediated 
events from GABA-ergic ones, an ATP-free internal 
solution and 3 µM bicuculline were used. In addition, 
to suppress the possible activation of glutamate 
receptors, 5 µM NBQX and 5 µM D-AP5 were 
routinely added to the external solution. The SDCN 
region in slices was visualized using video-enhanced 
infrared microscopy, and individual SDCN neurons 
were chosen for recording due to their morphology. 
Spontaneous sIPSCs and evoked ones (eIPSCs) were 
recorded in a whole-cell recording mode at a V
H
 of 
0 mV under voltage-clamp conditions. In order to 
achieve eIPSCs from SDCN neurons, the stimulation 
electrode was positioned near the central canal region. 
Short negative pulses (5-10 μA, 100 μsec long) were 
applied through a glass pipette filled with the standard 
external solution via a stimulus isolation unit.
Synaptic bouton preparation.  Both sIPSCs 
and eIPSCs were recorded from synaptic bouton 
preparations. In recordings of eIPSCs at single 
glycinergic synapses, the electrical focal stimulation 
pipette was placed close to the surface of a dissociated 
SDCN neuron, from which whole-cell recording was 
made. Then, negative pulses (100 µsec long) were 
delivered every 3 or 5 sec. The stimulating pipette 
having about a 0.5 μm diameter was filled with the 
standard external solution and moved along the surface 
of the somatic membrane and proximal dendrites until 
an eIPSC was elicited in an “all-or-none” fashion, 
indicating that the stimulating pipette (electrode) 
was positioned just above the bouton. The current 
appeared in an “all or none” fashion when the stimulus 
strength was increased or when the stimulation pipette 
was moved. The current was highly sensitive to 
0.3 µM tetrodotoxin (TTX) [23]. The success ratio 
(R
suc
) was measured as a ratio of the number of eIPSC
S
/
the number of focal stimulations with or without  GB. 
For example, 24 eIPSC
S
/30 focal stimulations gives 
R
suc
 = 0.8. The eIPCSs appeared like in an “all or 
none” fashion, but the amplitude histogram of eIPSCs 
recorded in the normal external solution with 2 mM 
Ca2+ could be fitted by Poisson process. 
Data analysis. Glycinergic IPSCs were counted and 
analyzed in preset epochs before, during, and after 
each test condition using the MiniAnalysis Program 
(Synaptosoft, USA). Briefly, the events were initially 
screened automatically using an amplitude threshold 
of 10 pA and then visually accepted or rejected based 
on their 10 to 90% rise and 90 to 37% decay times. The 
interevent intervals and amplitudes of sIPSCs were 
examined by constructing and comparing cumulative 
probability distributions under different conditions 
using the Kolmogorov–Smirnov (K–S) test (Stat View 
software, SAS Institute, USA).  The average values 
of both frequency and amplitude of synaptic events 
during the control period (3-5 min) were calculated, 
and the frequency and amplitude of all events in 
the course of drug application were normalized to 
these values. The effects of drugs were quantified as 
percentage changes in the frequency and amplitude 
of synaptic events and compared with the individual 
control. Possible differences between the amplitude 
and frequency distributions were tested by Student’s 
paired two-tailed t-test using their absolute values. On 
the other hand, the interevent intervals and amplitudes 
of a large number of synaptic events obtained from 
the same neuron were examined by constructing 
cumulative probability distributions and compared 
using the K–S test within the MiniAnalysis Program.
The current amplitude of eIPSCs was analyzed using 
pCLAMP 8.0. Numerical values are reported as means ± 
± s.e.m. A possible significance of the differences 
in the amplitude was tested by Student’s paired two-
tailed t-test using the absolute values of the parameter 
(not normalized ones). The differences with P < 0.05 
were considered to be significant. 
Drugs exposure. The following drugs were used 
in this study: TTX, bicuculline methiobromide, 
strychnine, and GB (Sigma, USA). All drugs were 
stored frozen (–20°C) as concentrated stock solutions 
and dissolved in the extracellular solution to the 
appropriate concentration just before recording. All 
test solutions containing drugs were applied by a 
standard gravity bath perfusion system at a flow rate 
of 2 to 3 ml/min for slice preparations and by  a “Y-
tube system” for rapid solution exchange within 
20 msec in experiments on dissociated neurons [25].
RESULTS
First, we examined the effect of GB on sIPSCs recorded 
in spinal cord slices. Bath application of 1.0 µM GB 
exerted negligible effects on the sIPSC amplitude 
and frequency (data not illustrated). At a higher 
GB concentration (10 µM), strong inhibition was 
observed, with the mean IPSC amplitude decreasing 
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to 61 ± 6.4%, while the frequency decreased to 78 ± 
± 9% (n = 4).  
The amplitude of eIPSCs was randomly distributed 
varying between 50 and 350 pA. When 1.0 µM GB 
dissolved in the standard extracellular solution was 
applied, a slight decrease in the eIPSC amplitude 
was observed without affecting the R
suc
 (Fig. 1B, C). 
However, application of GB at a higher concentration 
(10 µM) significantly decreased the eIPSC amplitude 
(n = 4, P < 0.05) and also decreased slightly the R
suc
 
(P > 0.05), as shown in Fig. 1 B, C. Moreover, 10 
µM GB profoundly changed the inactivation kinetics 
of evoked glycinergic currents being indicative of a 
channel mode of the inhibitory action, as reported by 
Kondratskaya et al. (2004). In the responses shown 
in Fig. 1D, the half-decay time was 33 msec for the 
control and changed to 20 msec in the presence of 
10 µM GB. 
Spontaneous IPSCs were also observed in dissociated 
SDCN neurons (synaptic bouton preparations) at the 
Fig. 1. Effects of ginkgolide B (GB) on glycinergic evoked inhibitory postsynaptic currents (eIPSCs) recorded from neurons of the sacral 
dorsal commissural nucleus (SDCN) in rat spinal cord slices.
A) Schematic illustration of the SDCN region (shown by an ellipse on the cord section) and positions of recording (Rec) and stimulation 
(Stim) electrodes. B)  Amplitudes of representative recordings of eIPSCs (pA) before and during application of GB (1 and 10 µM) shown 
by dashed bars above the diagram. C) Summary of the GB effect on the normalized amplitude and success ratio (R
suc
) (%) of eIPSCs;  n = 5, 
* P < 0.05 C. D) Original traces of eIPSCs recorded before and during application of 10 µM GB, and currents normalized by peak before 
and after GB application (1 and 2, respectively). 
Р и с. 1. Вплив гінкголіду Б (GB) на викликані гліцинергічні гальмівні постсинаптичні струми, зареєстровані в нейронах сакрального 
дорсального комісурального ядра у зрізах спинного мозку щура.  
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holding potential (V
H
) of 0 mV in a whole-cell patch 
recording configuration (Fig. 2A). In the experiments, 
contamination by glutamatergic sEPSCs and GABA-
ergic sIPSCs was removed pharmacologically. All 
sIPSCs could be completely inhibited by a competitive 
glycine receptor antagonist, strychnine (1 µM), 
indicating that the recorded sIPSCs are mediated by 
strychinine-sensitive  glycine receptors. Both the 
amplitude and frequency of  sIPSCs were decreased by 
GB (1 µM), suggesting that dissociated preparations 
are more sensitive than slice ones (Fig. 2A, 2, right 
panel).
Glycinergic eIPSCs evoked by electrical focal 
simulation of single glycinergic boutons using 
“synaptic bouton” preparations are also shown in 
Fig. 2A [13, 17]. Strychinine (1 µM) reversibly 
inhibited these eIPSCs even if the current strength of 
focal stimulation was increased. By recording eIPSCs 
at the V
H
  between +30 mV and –110 mV, the mean 
reversal potential estimated from the corresponding 
I-V relationship was –73.1 mV (n = 4, Fig. 2B). This 
value was close to the E
Cl 
(–69.9 mV) calculated from 
the Nernst equation using the [Cl-]i = 10 mM and 
[Cl-]
o
 = 161 mM values for internal and external 
Fig. 2. Glycinergic eIPSCs and sIPSCs observed in dissociated SDCN neurons (in a synaptic bouton preparation).
In A: panel a) Typical IPSCs evoked by focal stimulation (eIPSPs) of a single glycinergic bouton before and after application of 1 µM 
strychinine, Stry (shown by downward arrow). Many spontaneous IPSPs (sIPSPs) were recorded simultaneously from the same neuron. 
Focal stimulation was given at every 5 sec. Arrow 1 shows an eIPSP before Stry application; arrow 2 shows the absence of an eIPSP upon 
Stry application (the respective fragments 1 and 2 in dotted frames are presented at an expanded sweep scale). Inset at the right) Schematic 
illustration of a “synaptic bouton” preparation with positions of recording and stimulation electrodes. Panel b is analogous to panel B in 
Fig. 1; application of Stry  reversibly inhibits both eIPSCs and sIPSCs. B) Current-voltage (I-V) relationship for eIPSCs induced by focal 
stimulation of a single glycinergic bouton. The mean amplitudes (I, pA) are plotted vs the holding potential V
H
 (V, mV). Insets 1-3 show typical 
eIPSCs at different V
H
 values. The reversion potential E
r
 and chloride equilibrium potential E
Cl
 are indicated.  
Р и с. 2. Гліцинергічні викликані та спонтанні гальмівні постсинаптичні струми в дисоційованих нейронах сакрального дорсального 
комісурального ядра (препарат синаптичного з’єднання).
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solutions, respectively. These results indicate that 
eIPSC is a Cl- current passing through glycine-gated 
chloride channels.
The effect of GB (1 and 10 µM) on eIPSCs elicited 
at every 5 sec was examined by focal stimulation of 
a single glycinergic bouton. Application of 1 µM GB 
slightly decreased the eIPSC amplitude, as shown in 
Fig. 3A, B. At the same time, the R
suc
 for eIPSCs was 
also somewhat decreased. Gingkolide B applied in 
the concentration of 10 µM significantly decreased 
both the eIPSC amplitude and R
suc
 (not illustrated). 
In addition, as is seen in Fig. 3C, the inactivation 
kinetics of eIPSC was accelerated in the presence of 
GB, indicating channel-blocker features for the GB 
effect.
DISCUSSION
Our data confirmed the inhibitory action of GB 
on glycine receptors previously reported for the 
active compound of Ginkgo biloba extract (GB) on 
glycine currents in spinal cord neurons. The details 
of the effect of the potent blocker GB on glycinergic 
transmission within the SDCN neuronal circuitry are 
reported at first. An additional new finding of this our 
Fig. 3. The  effect of ginkgolide B (GB) on eIPSCs in a single glycinergic synapse.
A)  Amplitudes of eIPSCs (pA) induced by repeated stimulation (abscissa, numbers of stimuli) and recorded before and during application 
of 1 µM GB and during the recovery. Focal stimulation was given every 5 sec. Analysis during GB application (filled circles) was made for 
2 min 30 sec. Inset at the right is the same as in Fig.2A. B) Summarized results of the action 1 µM GB on the normalized eIPSC amplitude 
(n = 4, P < 0.05) and R
suc 
(%, n = 4, P < 0.05). * P < 0.05. C) Original traces of eIPSCs with or without the action of 1 µM GB. Currents 
normalized by the peak value are shown in the control (1) and after 1 µM GB application (2).
Р и с. 3. Вплив гінкголіду Б на викликані гальмівні постсинаптичні струми в поодинокому гліцинергічному синапсі. 
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study is the evidence for GB action as a modulator of 
the presynaptic glycine release machinery. 
Recently, the potent antagonistic activity of 
ginkgolides with respect to inhibitory glycine-activated 
receptors was reported [24]. The analysis of receptor-
drug relationships for a wild type and selected point 
mutations of the channel-forming subunit of glycine 
receptors has revealed the use-dependent channel 
blocking potency for GB, as well as its selectivity to 
β subunit-containing glycine receptors [11, 18]. The 
latter point is indicative of the GB-induced blockade 
of postsynaptic glycine receptors. In the present 
study, we have combined the experiments on rat 
spinal cord slices and acutely isolated SDCN neurons 
to examine the efficacy of GB as a receptor blocker 
within the framework of synaptic, extrasynaptic, and 
mixed patterns of native glycine receptor-mediated 
transmission.
It is well documented that the inhibitory postsynaptic 
events in spinal cord slices are mediated by co-release 
of GABA and glycine within the same synaptic space 
and, in turn, by activation of both GABA and glycine 
receptors [19]. Glycinergic postsynaptic events were 
isolated, as described earlier [23]. The action of 1 µM 
GB was examined on glycinergic sIPSCs recorded 
from neurons in slices and acutely isolated units. We 
found that 1 µM GB influences sIPSCs in slices with a 
low efficacy but with an increased potency when used 
in the concentration of 10 µM. 
With a purpose to further determine the effect of GB, 
we examined its action on glycine-elicited currents 
in freshly isolated SDCN neurons. An additional set 
of the experiments aimed to observe the effect of the 
examined drug on IPSCs evoked by focal stimulation of 
single synaptic boutons was performed. Postsynaptic 
currents evoked by focal single-bouton stimulations 
reflect the features of glycine receptor-mediated 
events, since they were insensitive to bicuculline 
and reversibly abolished by a competitive antagonist, 
strychnine (1 µM). Moreover, the reversal potential 
for evoked postsynaptic currents was estimated as 
–73.1 mV, which is rather close to the  E
Cl 
calculated 
from Nernst equation for chloride ions (–69 mV). 
The kinetic features were compared for eIPSCs in 
the control and after GB pre-incubation (10 µM). The 
half-decay time (τ
1
) for control eIPSCs was calculated 
as 33 msec, whereas the half-decay time (τ
2
) for 
eIPSCs in the presence of GB (10 min pre-perfusion) 
was significantly reduced and comprised 20 msec. 
Such acceleration of the current kinetics is indicative 
of the channel blocking action of GB, as was reported 
earlier [20]. In isolated neurons, 1 µM GB did cause 
a slight decrease in the average eIPSC amplitude and 
R
suc
, while 10 µM GB led to a significant reduction 
of the amplitude and R
suc
, suggesting that GB acts not 
only on post-synaptic glycine-gated Cl– channels but 
also on the pre-synaptic glycine release machinery, i.e., 
this agent reduces the release probability. The details 
of the presynaptic effect of GB remain uncertain and 
require further examination. 
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Р е з ю м е
Вплив гінкголіду В (GB) – діючої сполуки екстракту з гінк-
го дволопатевого (Ginkgo biloba)  на гліцинопосередкова-
ні синаптичні струми вивчався на нейронах спінального са-
крального дорсального комісурального ядра (SDCN) щурів. 
Гальмівні постсинаптичні струми (ГПСС), викликані в пре-
паратах зрізів спинного мозку, дозозалежно зменшували-
ся при аплікації GB. Амплітуда викликаних ГПСС під дією 
10 мкМ GB падала до 61 ± 6.4 % з одночасним прискорен-
ням кінетики струмів, що свідчило про наявність впливу на 
канальні пори. Як амплітуда, так і відносна кількість си-
наптичних подій (викликаних ГПСС), індукованих елек-
тричною фокальною стимуляцією  поодиноких гліцинер-
гічних нервових закінчень (бутонів), також зменшувались 
у присутності 1 мкМ GB. Ці результати свідчать, що GB не 
тільки модулює постсинаптичні гліцинові рецептори, але й 
впливає на пресинаптичні механізми вивільнення гліцину. 
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